SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed Therapy

被引:2
|
作者
Sun, Lova [1 ]
Surya, Sanjna [1 ]
Goodman, Noah G. [1 ]
Le, Anh N. [1 ]
Kelly, Gregory [1 ]
Owoyemi, Olutosin [1 ]
Desai, Heena [1 ]
Zheng, Cathy [1 ]
DeLuca, Shannon [1 ]
Good, Madeline L. [1 ]
Hussain, Jasmin [2 ]
Jeffries, Seth D. [1 ]
Kry, Yolanda R. [2 ]
Kugler, Emily M. [1 ]
Mansour, Maikel [2 ]
Ndicu, John [1 ]
Osei-Akoto, Annaclaire [3 ]
Prior, Timothy [2 ]
Pundock, Stacy L. [1 ]
Varughese, Lisa A. [3 ]
Weaver, JoEllen [3 ]
Doucette, Abigail [4 ]
Dudek, Scott [3 ]
Verma, Shefali Setia [3 ]
Gouma, Sigrid [5 ]
Weirick, Madison E. [5 ]
McAllister, Christopher M. [5 ]
Bange, Erin [1 ]
Gabriel, Peter [4 ,6 ]
Ritchie, Marylyn [3 ]
Rader, Daniel J. [3 ]
Vonderheide, Robert H. [1 ,6 ]
Schuchter, Lynn M. [1 ,6 ]
Verma, Anurag [3 ]
Maillard, Ivan [1 ,6 ]
Mamtani, Ronac [1 ,6 ]
Hensley, Scott E. [5 ]
Gross, Robert [7 ]
Wileyto, E. Paul [8 ]
Huang, Alexander C. [1 ,6 ]
Maxwell, Kara N. [1 ,3 ,6 ]
DeMichele, Angela [1 ,6 ]
机构
[1] Univ Penn, Dept Med, Div Hematol Oncol, Perelman Sch Med, Philadelphia, PA USA
[2] Univ Penn, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA USA
[3] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA USA
[4] Univ Penn, Dept Radiat Oncol, Perelman Sch Med, Philadelphia, PA USA
[5] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA
[6] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA
[7] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA USA
[8] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA USA
基金
美国国家卫生研究院;
关键词
COVID-19; IMPACT;
D O I
10.1200/OP.21.00113
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE Multiple studies have demonstrated the negative impact of cancer care delays during the COVID-19 pandemic, and transmission mitigation techniques are imperative for continued cancer care delivery. We aimed to gauge the effectiveness of these measures at the University of Pennsylvania. METHODS We conducted a longitudinal study of SARS-CoV-2 antibody seropositivity and seroconversion in patients presenting to infusion centers for cancer-directed therapy between May 21, 2020, and October 8, 2020. Participants completed questionnaires and had up to five serial blood collections. RESULTS Of 124 enrolled patients, only two (1.6%) had detectable SARS-CoV-2 antibodies on initial blood draw, and no initially seronegative patients developed newly detectable antibodies on subsequent blood draw(s), corresponding to a seroconversion rate of 0% (95% CI, 0.0 TO 4.1%) over 14.8 person-years of follow up, with a median of 13 health care visits per patient. CONCLUSION These results suggest that patients with cancer receiving in-person care at a facility with aggressive mitigation efforts have an extremely low likelihood of COVID-19 infection. (C) 2021 by American Society of Clinical Oncology
引用
收藏
页码:748 / +
页数:9
相关论文
共 50 条
  • [41] Vaccination against SARS-CoV-2 in cancer patients
    von Lilienfeld-Toal, Marie
    Rieger, Christina
    Giesen, Nicola
    Woermann, Bernhard
    ONKOLOGE, 2021, 27 (07): : 691 - 696
  • [42] SARS-COV-2 infection in patients with cancer undergoing checkpoint blockade: Clinical course and outcome
    Di Giacomo, Anna M.
    Gambale, Elisabetta
    Monterisi, Santa
    Valente, Monica
    Maio, Michele
    EUROPEAN JOURNAL OF CANCER, 2020, 133 : 1 - 3
  • [43] Effectiveness and tolerability of SARS-CoV-2 vaccination in patients undergoing radiotherapy
    Geinitz, H.
    Silberberger, E.
    Spiegl, K.
    Feichtinger, J.
    Track, C.
    Weis, E.
    Venhoda, C.
    Huppert, R.
    Braeutigam, E.
    Aschacher, B.
    Kocik, L.
    Karasek, N.
    Fischerlehner, B.
    Gruber, G.
    Bihary, D. V.
    Erdei, M.
    Kirchner, K.
    Zauner-Barbor, G.
    Ecker, M.
    Spindelbalker-Renner, B.
    Adler, R.
    Thoene, P.
    Dieplinger, B.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1250 - S1251
  • [44] A double-e dge d sword: Prolonged detection of SARS-COV-2 in patients receiving cancer directed therapy
    Wong, Winston
    Brieva, Claire
    May, Michael
    Gambina, Karen
    Whittier, Susan
    Hod, Eldad A.
    Pellicciotta, Ilenia
    Pan, Samuel
    Hu, Jianhua
    Abbott, Maura
    Schwartz, Gary K.
    Manji, Gulam A.
    SEMINARS IN ONCOLOGY, 2021, 48 (02) : 166 - 170
  • [45] Nosocomial Pneumoniae in Patients with SARS-CoV-2 ARDS undergoing NIV
    Olmati, Federica
    Oliva, Alessandra
    Baiocchi, Pia
    Petroianni, Angelo
    Tomsa, Corina
    Paciucci, Gianluca
    Mirabelli, Flavio
    Mastroianni, Claudio Maria
    Palange, Paolo
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [46] Prognostic value of SARS-CoV-2 on patients undergoing cardiac surgery
    Bonalumi, Giorgia
    Casado, Alberto Pilozzi
    Barbone, Alessandro
    Garatti, Andrea
    Colli, Andrea
    Giambuzzi, Ilaria
    Torracca, Lucia
    Ravenni, Giacomo
    Folesani, Gianluca
    Murara, Giacomo
    Pantaleo, Antonio
    Piciche, Marco
    Villa, Emmanuel
    Ferraro, Francesco
    Vendramin, Igor
    Livi, Ugolino
    Montalto, Andrea
    Musumeci, Francesco
    Tarzia, Vincenzo
    Trumello, Cinzia
    De Bonis, Michele
    Margari, Vito
    Paparella, Domenico
    Salsano, Antonio
    Santini, Francesco
    Nicolardi, Salvatore
    Patane, Francesco
    Mammana, Liborio
    Stura, Erik Cura
    Rinaldi, Mauro
    Massi, Francesco
    Triggiani, Michele
    Grazioli, Valentina
    Giroletti, Laura
    Rubino, Antonino
    De Feo, Marisa
    Audo, Andrea
    Regesta, Tommaso
    Barili, Fabio
    Gerosa, Gino
    Di Mauro, Michele
    Parolari, Alessandro
    JOURNAL OF CARDIAC SURGERY, 2022, 37 (01) : 165 - 173
  • [47] Universal testing for SARS-Cov-2 in patients undergoing anticancer treatment
    Guerini, A. E.
    Magrini, S. M.
    Borghetti, P.
    Volpi, G.
    Luca, T.
    Costa, L.
    Pegurri, L.
    Guaineri, A.
    Imbrescia, J.
    Ranghetti, E.
    Premi, A.
    Donofrio, A.
    Spiazzi, L.
    Buglione, M.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1225 - S1225
  • [48] Seropositivity for SARS-CoV-2 in a General Population: How Specific Is the Diagnostic?
    Lyu, Zhaoqing
    Fujitani, Tomoko
    Harada, Kouji H.
    JOURNAL OF EPIDEMIOLOGY, 2023, 33 (01) : 62 - 62
  • [49] Differences of characteristics and outcomes between cancer patients and patients with no active cancer hospitalised for a SARS-CoV-2 infection
    Fenioux, Charlotte
    Allenbach, Yves
    Vozy, Aurore
    Salem, Joe-Elie
    Maalouf, Georgina
    Vieira, Matheus
    Le Joncour, Alexandre
    Benveniste, Olivier
    Saadoun, David
    Frere, Corinne
    Campedel, Luca
    Salem, Pierre
    Gligorov, Joseph
    Funck-Brentano, Christian
    Cacoub, Patrice
    Gougis, Paul
    BULLETIN DU CANCER, 2021, 108 (06) : 581 - 588
  • [50] SARS-CoV-2 seropositivity in African women living with HIV and their infants
    Matubu, Taguma A.
    Yende-Zuma, Nonhlanhla
    Brummel, Sean S.
    Stranix-Chibanda, Lynda
    Ogwang, Lillian Wambuzi
    Dadabhai, Sufia
    Atuhaire, Patience
    Chauwa, Felluna
    Gadama, Luis
    Fernandez, Reinaldo E.
    Aizire, Jim
    Jackson, Jbrooks
    Tobian, Aaron A. R.
    Taha, Taha E.
    Fowler, Mary Glenn
    BMC INFECTIOUS DISEASES, 2024, 24 (01)